Literature DB >> 9759687

Underuse of venous thromboembolism prophylaxis for general surgery patients: physician practices in the community hospital setting.

D W Bratzler1, G E Raskob, C K Murray, L J Bumpus, D S Piatt.   

Abstract

BACKGROUND: Venous thromboembolism is a common complication of surgery. Although surveys of physician self-reported practices have suggested near universal support for routine use of measures to prevent venous thromboembolism, medical record auditing has demonstrated underuse.
OBJECTIVE: To assess physician practices of venous thromboembolism prophylaxis in the community hospital setting.
METHODS: Retrospective review of the medical records from 20 hospitals in Oklahoma of 419 Medicare patients aged 65 years or older undergoing major abdominothoracic surgery between April 1 and December 31, 1995. Utilization rates of prophylaxis stratified according to patient risk for venous thromboembolism were measured.
RESULTS: Prophylaxis measures were implemented for only 160 (38%) of 419 patients studied (95% confidence interval, 33%-43%). There was little variation in the use of prophylaxis based on the risk for venous thromboembolism. Only 97 (39%) of 250 patients (95% confidence interval, 33%-45%) at very high risk received any form of prophylaxis and of these 97, only 64 patients (66%) received appropriate measures (95% confidence interval, 56%-75%).
CONCLUSIONS: Despite widely disseminated, evidence-based recommendations, venous thromboembolism prophylaxis is underused in Medicare patients undergoing major abdominothoracic surgery in community hospitals in Oklahoma.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9759687     DOI: 10.1001/archinte.158.17.1909

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  11 in total

Review 1.  Incorporating preventive care recommendations into clinical practice: how do we bridge the gap?

Authors:  J D Douketis
Journal:  CMAJ       Date:  1999-04-20       Impact factor: 8.262

Review 2.  The post-thrombotic syndrome: the forgotten morbidity of deep venous thrombosis.

Authors:  Susan R Kahn
Journal:  J Thromb Thrombolysis       Date:  2006-02       Impact factor: 2.300

Review 3.  A systematic review of strategies to improve prophylaxis for venous thromboembolism in hospitals.

Authors:  Rebecca Tooher; Philippa Middleton; Clarabelle Pham; Robert Fitridge; Siohban Rowe; Wendy Babidge; Guy Maddern
Journal:  Ann Surg       Date:  2005-03       Impact factor: 12.969

Review 4.  Management of venous thromboembolism in the elderly.

Authors:  Alex C Spyropoulos; Geno Merli
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

5.  Evaluation of the efficacy of venous thromboembolism prophylaxis guideline implementation in Japan.

Authors:  Kiyoaki Niimi; Masayoshi Kobayashi; Hiroshi Narita; Kiyohito Yamamoto; Kimihiro Komori
Journal:  Surg Today       Date:  2010-11-26       Impact factor: 2.549

Review 6.  Bridging the gap between evidence and practice in venous thromboembolism prophylaxis: the quality improvement process.

Authors:  Franklin A Michota
Journal:  J Gen Intern Med       Date:  2007-09-22       Impact factor: 5.128

7.  Development of national performance measures on the prevention and treatment of venous thromboembolism.

Authors:  Dale W Bratzler
Journal:  J Thromb Thrombolysis       Date:  2010-02       Impact factor: 2.300

Review 8.  Current issues in thromboprophylaxis in the elderly.

Authors:  Parminder S Chaggar; Kevin S Channer
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

Review 9.  Proficient and cost-effective approaches for the prevention and treatment of venous thrombosis and thromboembolism.

Authors:  R L Bick
Journal:  Drugs       Date:  2000-09       Impact factor: 11.431

10.  Thromboprophylaxis use in medical and surgical inpatients and the impact of an electronic risk assessment tool as part of a multi-factorial intervention. A report on behalf of the elVis study investigators.

Authors:  Edward Janus; Anmol Bassi; David Jackson; Harshal Nandurkar; Mark Yates
Journal:  J Thromb Thrombolysis       Date:  2011-10       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.